Medication Guide - 12/6/2021

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Actiq Fentanyl Citrate TROCHE/LOZENGE;TRANSMUCOSAL 020747 CEPHALON 12/03/2021 Fentanyl Citrate Fentanyl Citrate TROCHE/LOZENGE;TRANSMUCOSAL 078907 SPECGX LLC 12/03/2021 Fentora Fentanyl Citrate TABLET;BUCCAL, SUBLINGUAL 021947 CEPHALON 12/03/2021 Inrebic Fedratinib Hydrochloride CAPSULE;ORAL 212327 IMPACT 12/03/2021 Keytruda Pembrolizumab SOLUTION;INTRAVENOUS 125514 MERCK SHARP DOHME 12/03/2021 Lazanda Fentanyl Citrate SPRAY, METERED;NASAL 022569 BTCP PHARMA 12/03/2021 Onsolis Fentanyl Citrate FILM;BUCCAL 022266 BDSI 12/03/2021 Subsys Fentanyl SPRAY;SUBLINGUAL 202788 BTCP PHARMA 12/03/2021 Tafinlar Dabrafenib Mesylate CAPSULE;ORAL 202806 NOVARTIS 12/03/2021 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA